BSE SENSEX
BSE SENSEX
The BSE SENSEX, also known as the S&P BSE SENSEX, is a stock market index of 30 well-established and financially sound companies listed on the Bombay Stock Exchange (BSE) in Mumbai, India. The term "SENSEX" is a portmanteau of the words "Sensitive" and "Index". It is one of the oldest stock market indices in India, having been introduced in 1986.
History
The BSE SENSEX was first compiled in 1986, and it is considered a benchmark index for the Indian stock market. The base year of the SENSEX is 1978-79, and the base value is 100. The index is calculated based on a free-float market capitalization methodology, which was adopted in 2003.
Calculation Methodology
The SENSEX is calculated using the free-float market capitalization method. This method takes into account the proportion of shares readily available for trading in the market. The formula for calculating the SENSEX is:
SENSEX = (Sum of Free-float Market Capitalization of 30 companies) / (Base Market Capitalization) * Base Index Value (100)
Constituent Companies
The SENSEX comprises 30 companies from various sectors, representing a sample of large, liquid, and representative companies. These companies are selected by the Index Committee of the BSE, which includes academicians, mutual fund managers, and other market participants.
Significance
The SENSEX is widely regarded as a barometer of the Indian economy. It reflects the overall market sentiment and the performance of the major companies listed on the BSE. Investors, analysts, and policymakers closely monitor the SENSEX to gauge the health of the Indian stock market and the economy.
Milestones
The SENSEX has achieved several significant milestones since its inception. Some of the notable milestones include:
- Crossing the 1,000 mark in July 1990
- Reaching the 10,000 mark in February 2006
- Surpassing the 20,000 mark in October 2007
- Crossing the 50,000 mark in February 2021
Related Indices
The BSE SENSEX is part of a family of indices that includes:
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen, Prab R. Tumpati, MD